Major players benefit from industry consolidation
This article was originally published in Clinica
Executive Summary
Consolidation in the medical devices and diagnostics industry over the last 10 years has reinforced the position of the large players to the benefit of both US and EU companies. According to the LEK consultancy, the combined market share of the top 30 European and US companies increased from 49% in 1988 to 56% in 1992 (US companies 35%, EU 21%):